Anticholinergic therapy for bronchiectasis

Cochrane Database of Systematic Reviews

Volumn 2011, Issue 6, 2001, Pages

  Lasserson, Toby J ^a   Holt, Kay ^b   Evans, David J ^c   Milan, Stephen J ^d   Greenstone, Michael ^e  

^a The Cochrane Collaboration   (United Kingdom)

^b UK   (United Kingdom)

^c Hemel Hempstead General Hospital   (United Kingdom)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

^e CASTLE HILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT;

ACUTE DISEASE; BRONCHIECTASIS; HUMAN; REVIEW;

ACUTE DISEASE; BRONCHIECTASIS; CHOLINERGIC ANTAGONISTS; HUMANS;

EID: 84921537644     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD002163     Document Type: Article

References (7)

1. Abu Hassan J, Saadiah S, Roslan H, Zainudin BMZ. Bronchodilator response to inhaled beta-2 agonist and anticholinergic drugs in patients with bronchiectasis. Respirology 1999;4:423-6.
2. Sturani C, Schiavina M, Tosi I, Zanasi A, Gunella G. Comparison of effects of Sympathicomimetic and parasympathicomimetic bronchidilators on airway obstruction in patients with bronchiectasis [Raffronto degli effeti dei broncodilatanti simpaticomimetici e parasimpaticolitici sull'ostruzione delle vie aeree nei pazienti bronchiectasici]. Lotta Contro la Tubercolosi e le Malattie Polmonari Sociali 1982;52:237-9.
3. Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 1994;272(19):1497-505.
4. Cherniack N, Bosti KL, Saxton GA, Lepper MH, Dowling HF. Pulmonary function tests in fifty patients with bronchiectasis. Journal of Laboratory & Clinical Medicine 1997;52:693-707.
5. Jones AP, Rowe BH. Bronchopulmonary hygiene physical therapy for chronic obstructive pulmonary disease and bronchiectasis (Cochrane review). Cochrane Database of Systematic Reviews 1998, Issue 4. [DOI: 10.1002/14651858.CD000045]
6. Murphy MB, Deen DJ, Fitzgerald MX. Atopy, immunological changes and respiratory function in bronchiectasis. Thorax 1984;31:179-84.
7. Wills P, Greenstone M. Inhaled hyperosmolar agents for bronchiectasis (Cochrane review). Cochrane Database of Systematic Reviews 2001, Issue 1. [DOI: 10.1002/14651858.CD002996.pub2]